News from biodel inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 06, 2010, 08:00 ET

Biodel to Report Fourth Quarter Fiscal Year 2010 Financial Results on December 9, 2010

Biodel Inc. (Nasdaq: BIOD) will issue its fourth quarter fiscal year 2010 financial results on December 9, 2010. Following the release of the...

Nov 12, 2010, 07:00 ET

Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting

Scientists from Biodel Inc. (Nasdaq: BIOD) reported new findings from the company's Linjeta™, insulin glargine, "smart" basal insulin and...

Nov 08, 2010, 06:00 ET

Biodel to Present Data from Product Development Programs at 2010 Diabetes Technology Meeting

 Biodel Inc. (Nasdaq: BIOD) announced today that the following abstracts describing recent findings from the company's product development...

Nov 02, 2010, 16:00 ET

Biodel Awarded $1.2 Million in Therapeutic Discovery Research Grants From IRS

Biodel Inc. (Nasdaq: BIOD) announced today that it has been awarded $1.2 million in research grants under the Internal Revenue Service's...

Nov 01, 2010, 06:00 ET

FDA Issues Complete Response Letter to Biodel Regarding New Drug Application for Linjeta™

Biodel Inc. (Nasdaq: BIOD) announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) requesting...

Sep 24, 2010, 07:00 ET

Biodel to Present at Upcoming Conferences

Biodel Inc. (Nasdaq: BIOD) announced today that it will be presenting at the following upcoming conferences: - Fifth Annual JMP Securities...

Sep 23, 2010, 09:23 ET

Biodel Reports Research Progress in Poster Session on Short-Acting Insulins at 46th EASD Annual Meeting

Biodel Inc. (Nasdaq: BIOD) today reported recent findings from the company's diabetes drug research program during a poster session on short-acting...

Sep 21, 2010, 06:00 ET

Results of Linjeta™ Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Annual Meeting

In a platform presentation at the 46th annual meeting of the European Association for the Study of Diabetes (EASD) in Stockholm, investigators for...

Sep 17, 2010, 07:30 ET

Biodel Appoints Arthur Urciuoli to its Board of Directors

Biodel Inc. (Nasdaq: BIOD) announced today the appointment of Arthur Urciuoli to the company's board of directors.  Mr. Urciuoli is chairman...

Sep 01, 2010, 07:00 ET

Biodel Announces Name Change for Lead Product Candidate

Biodel Inc. (Nasdaq: BIOD) announced today that Linjeta™ (pronounced lin-JET-uh) will replace VIAject as the proposed trade name for Biodel's...

Aug 25, 2010, 09:25 ET

Biodel to Raise $9.4 Million Through Registered Direct Offering

Biodel Inc. (Nasdaq: BIOD) today announced that it has entered into definitive agreements with two institutional investors to sell 2,398,200 shares...

Aug 05, 2010, 16:00 ET

Biodel Reports Third Quarter Fiscal Year 2010 Financial Results

Biodel Inc. (Nasdaq: BIOD) today reported financial results for the third quarter ended June 30, 2010. Third Quarter Financial Results Biodel...

Jul 30, 2010, 07:00 ET

Biodel to Report Third Quarter Fiscal Year 2010 Financial Results on August 5, 2010

Biodel Inc. (Nasdaq: BIOD) will issue its third quarter fiscal year 2010 financial results on August 5, 2010. Following the release of the...

Jul 29, 2010, 07:00 ET

Biodel to Present at the Wedbush Life Sciences Conference

Biodel Inc. (Nasdaq: BIOD) announced today that the Company will present at the Wedbush Securities Life Sciences Best Ideas Management Access...

Jul 12, 2010, 19:00 ET

Biodel Reports Progress with Development of Glucose-Regulated 'Smart' Basal Insulin

Biodel Inc. (Nasdaq: BIOD) today reported results of preclinical tests which demonstrated the potential of the company's glucose-regulated or...

Jul 12, 2010, 07:00 ET

Biodel Announces Research Grants by Juvenile Diabetes Research Foundation to Evaluate Use of VIAject® in Treatment of Diabetes

Biodel Inc. (Nasdaq: BIOD) announced today the award of two research grants by the Juvenile Diabetes Research Foundation (www.jdrf.org) to Stanford...

Jul 06, 2010, 07:00 ET

Biodel Announces Schedule for Presentations at the 37th Annual Meeting and Exposition of the Controlled Release Society

Biodel Inc. (Nasdaq: BIOD) announced today that the following oral and poster presentations describing results from studies of the company's...

Jul 01, 2010, 16:00 ET

Biodel Abstracts to be Presented at 46th Annual Meeting of European Association for the Study of Diabetes

Biodel Inc. (Nasdaq: BIOD) announced today that the following abstracts describing results from studies of the company's product candidates have...

Jun 26, 2010, 10:00 ET

Studies Demonstrate Potential Benefits of More-Rapid-Acting Injectable Insulins: Poster Presentations at Annual Meeting of the American Diabetes Association

Studies of a more-rapid-acting injectable human insulin formulation (VIAject®) in the treatment of type 1 and type 2 diabetes and of a novel...

Jun 25, 2010, 17:00 ET

Final Results of Phase 3 Study of VIAject® vs. Regular Human Insulin in Patients with Type 2 Diabetes Presented at American Diabetes Association Annual Meeting

The final results of a six-month, multi-center, open-label Phase 3 study of VIAject® (more-rapid-acting injectable human insulin) versus...